Copyright
©The Author(s) 2004.
World J Gastroenterol. May 1, 2004; 10(9): 1382-1385
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1382
Published online May 1, 2004. doi: 10.3748/wjg.v10.i9.1382
Cases | Ang-2 (mean ± SD) | |
Primary gastric cancers | 72 | 0.497 ± 0.393a |
Adjacent normal tissues | 72 | 0.088 ± 0.224 |
Ang-2 expression (Cases) | VEGF expression (Cases) | P value | |
Positive | Negative | ||
Positive | 36 | 10 | 0.0055 |
Negative | 12 | 14 |
Pathological factors | No. of cases | Ang-2 mRNA (mean ± SD) | P value |
Tumor stage | |||
Early stage | 26 | 0.222 ± 0.310 | |
Advanced stage | 46 | 0.593 ± 0.318 | 0.017 |
Histological type | |||
Moderate-Poor differential type | 45 | 0.425 ± 0.350 | 0.908 |
High differential type | 27 | 0.203 ± 0.290 | |
Lymph node metastasis | |||
Positive | 48 | 0.413 ± 0.346 | 0.752 |
Negative | 24 | 0.490 ± 0.450 | |
Serosal invasion | |||
Positive | 43 | 0.404 ± 0.327 | 0.764 |
Negative | 29 | 0.334 ± 0.459 | |
Vascular involvement | |||
Positive | 46 | 0.640 ± 0.335 | 0.032 |
Negative | 26 | 0.272 ± 0.298 |
- Citation: Sun XD, Liu XE, Wu JM, Cai XJ, Mou YP, Li JD. Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 2004; 10(9): 1382-1385
- URL: https://www.wjgnet.com/1007-9327/full/v10/i9/1382.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i9.1382